Clinical trial
The Bio-equivalence Study of Iron Sucrose Injection in Healthy Participants
NCT06674486 is registered in ClinicalTrials.gov with Sichuan Huiyu Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Bio-equivalence Study of Iron Sucrose Injection in Healthy Participants
- Lead sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 22, 2024
- Completion date
- March 14, 2025
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bioequivalency, safety issues